NB-RISEDRONATE
NB PHARMA INC.
Quick answers
Is there a shortage of NB-RISEDRONATE in Canada?
No. There is no current shortage of NB-RISEDRONATE 35MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ACTONEL
ABBVIE CORPORATION
PHL-RISEDRONATE
PHARMEL INC
DOM-RISEDRONATE
DOMINION PHARMACAL
RIVA-RISEDRONATE
LABORATOIRE RIVA INC.
PENDO-RISEDRONATE
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Q-RISEDRONATE
QD PHARMACEUTICALS ULC
DIN
02561859
Strength
35MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
See all RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NB PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
5MG · DIN 02556715
2.5MG · DIN 02556707
10MG · DIN 02556723
5MG · DIN 02553643
2.5MG · DIN 02553635
10MG · DIN 02558564
5MG · DIN 02558556
10MG · DIN 02555999
20MG · DIN 02556006
150MG · DIN 02560089
75MG · DIN 02560070
300MG · DIN 02560097